HighVista Strategies »

Apogee Therapeutics shares owned by HighVista Strategies

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.9M 119k 66.45

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Merus N V (MRUS)
Microsoft Corporation (MSFT)
Arcellx Common Stock (ACLX)
Xpo Logistics Inc equity (XPO)
Nuvalent Inc-a (NUVL)
Ansys (ANSS)
Hess (HES)
Ideaya Biosciences (IDYA)
Juniper Networks (JNPR)
Sp Plus (SP)
Cerevel Therapeutics Hldng I (CERE)
Albertsons Cos Common Stock (ACI)

View all positions for HighVista Strategies

Top funds holding Apogee Therapeutics

VR Adviser
FMR
BlackRock
Perceptive Advisors
Fairmount Funds Management
RA Capital Management
Vanguard Group
Braidwell
Wellington Management Company
T. Rowe Price Associates
Franklin Resources
Darwin Global Management
Geode Capital Management
OrbiMed Advisors
Woodline Partners

View all funds holding Apogee Therapeutics